Literature DB >> 8318529

Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times.

G Blume1, G Cevc, M D Crommelin, I A Bakker-Woudenberg, C Kluft, G Storm.   

Abstract

One possibility for bringing drugs to their specific targets is to use the drug-laden liposomes that have been made target-specific by the attachment of appropriate proteins. Such 'directed' proteoliposomes and most other particles are rapidly removed from the bloodstream, however, by the mononuclear phagocytes in the liver and spleen. This causes suboptimal drug accumulation at the target site. Coating the liposome surface with poly(ethylene glycol) (PEG) may prolong the circulation time of liposomes. Using plasminogen as a homing device we have shown that the PEG-modified liposomes with such a homing device coupled to the ends of the long PEG chains may combine long vesicle circulation times in the blood with high target binding capability. The PEG-coated proteoliposomes with homing devices attached at the very bilayer surface, on the contrary, are longlived but have only little or no capability to bind to their targets.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318529     DOI: 10.1016/0005-2736(93)90039-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

Review 1.  Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.

Authors:  Alicia Fernandez-Fernandez; Romila Manchanda; Anthony J McGoron
Journal:  Appl Biochem Biotechnol       Date:  2011-09-27       Impact factor: 2.926

2.  Preparation and characterization of doxorubicin-loaded sterically stabilized immunoliposomes.

Authors:  N Emanuel; E Kedar; E M Bolotin; N I Smorodinsky; Y Barenholz
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

Review 3.  Polymer nanogels: a versatile nanoscopic drug delivery platform.

Authors:  Reuben T Chacko; Judy Ventura; Jiaming Zhuang; S Thayumanavan
Journal:  Adv Drug Deliv Rev       Date:  2012-02-10       Impact factor: 15.470

4.  Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions.

Authors:  Fuxin Shi; Luc Wasungu; Anita Nomden; Marc C A Stuart; Evgeny Polushkin; Jan B F N Engberts; Dick Hoekstra
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

5.  Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol).

Authors:  A K Kenworthy; S A Simon; T J McIntosh
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

6.  Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol).

Authors:  A K Kenworthy; K Hristova; D Needham; T J McIntosh
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

7.  Ligand-receptor interactions between surfaces: the role of binary polymer spacers.

Authors:  Gabriel S Longo; David H Thompson; I Szleifer
Journal:  Langmuir       Date:  2008-08-13       Impact factor: 3.882

Review 8.  Ligand liposomes and boron neutron capture therapy.

Authors:  Jörgen Carlsson; Erika Bohl Kullberg; Jacek Capala; Stefan Sjöberg; Katarina Edwards; Lars Gedda
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

9.  A neutron reflectivity study of polymer-modified phospholipid monolayers at the solid-solution interface: polyethylene glycol-lipids on silane-modified substrates.

Authors:  T L Kuhl; J Majewski; J Y Wong; S Steinberg; D E Leckband; J N Israelachvili; G S Smith
Journal:  Biophys J       Date:  1998-11       Impact factor: 4.033

10.  Streptavidin-biotin binding in the presence of a polymer spacer. A theoretical description.

Authors:  Chun-Lai Ren; Daniel Carvajal; Kenneth R Shull; Igal Szleifer
Journal:  Langmuir       Date:  2009-10-20       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.